Thailand Sidao Hospital

heir, that is, heir. Road is the path. The so-called inheritance path is the path to seeking a son, and all requests will be answered. Inheriting is inheritance. Tao is the law of pregnancy. The so-called inheritance path is to teach the path of pregnancy and help the world. Inheriting the path and eugenics originated from the Western Sto

rk The legend of the stork that gives birth to its children brings together famous doctors and experts from home and abroad to study the way of breeding.

Sidao Yougeng has long been concerned about reproductive health, pregnancy preparation, fertility preservation, and 1-3 generations of test tubes. He is committed to solving every fertility related need of modern people. It has a number of well-known hospitals in China for joint diagnosis and treatment

Green channel services enable joint diagnosis and treatment at home and abroad, shorten the time of stay abroad, and provide more families with all-round integrated eugenics and fertility solutions. The company's Sidao (Thailand) Reproductive Specialist Hospital

Located in downtown Bangkok, Thailand, it is certified by the Royal Thai College of Obstetricians and Gynaecology. A core expert team led by Dr. Chanin, a leading figure in Thailand's reproductive profession, provides comprehensive services to our customers. Assisted reproduction solutions n

Medical service hospitals such as genetic disease screening and diagnosis have their own genetic testing centers. They are one of the few reproductive institutions in Thailand that have independently developed PGT technology and have European and American standard laboratory systems., committed to making thousands of

Thousands of families can have a healthy baby.

Thailand's leading international medical team

Chanin Asvaahares (Dr. Channing) Honorary Director of Sidao (Thailand) Reproductive Specialist Hospital

tFather of the world's 4th test-tube baby

An authoritative international leader in the field of assisted reproduction

Thailand's medical standards and norms setter in the field of assisted reproduction

Founder of Personalized Immunotherapy for Thai Repeated Transplantation Failure

has taught at the Royal Medical College of Thailand and Mahidol University for 30 years. He also serves as a visiting professor at Humboldt University in Berlin, Kobe University in Japan, and DRK Hospital in Germany

An authoritative person with more than 30 years of clinical experience in the field of assisted reproduction. After receiving a postdoctoral doctor in 1978, he devoted himself to studying assisted reproductive medicine.

In 1984, he went to the historic and prestigious University of Heidelberg in Germany to continue his studies

While working at Belinson Hospital in Israel in 1988, the world's fourth ICSI baby was born. Since 2008, he has served as deputy chairman of the Assisted Reproduction Association of the Royal Association of Obstetricians and Gynaecology of Thailand

Laboratory hardware advantages European and American standard quality control systems ensurethesuccess rate of blastocyst culture

The laboratory invests heavily in the research and development and innovation of assisted reproductive technology every year. It is in line with international updates in real time, maintaining the current international frontier

technical level.

Entire culture system:

European and American standard laboratory culture system

High-end Device:

Embryo Real-time Monitoring System, German-made Laser Membrane Breaker

Data and Results:

Efficient and stable blastocyst culture system, fertilization rate and blastocyst formation rate maintain the internationally leading level

Advantages of embryo screening technology Core technology of the third generation test tube

Based on the whole genome SNP chip and the world's leading Karyomapping technology, 23 pairs of chromosomes or single cells of embryos are tested for aneuploidy, monogenic genetic diseases, and chromosomal structural abnormalities

Compared with sequencing methods, screening high-quality embryos can greatly improve the utilization of embryos and avoid waste by tracing the error of embryo chimerism.

PGT-A inspection

Based on WGA technology and SNP-Array technology, the whole genome is amplified at the single cell level, the whole genome is analyzed, and the embryos submitted are tested for chromosome aneuploidy, including more than 4M

Fragment deleted/duplicated, CNLOH above 10M.

PGT-M Inspection

1. Chromosome copy number variation (CNV);2. Gene mutation carrying status detection

Example

(1) Detected disease name: X-linked severe combined immunodeficiency type 1: X-linked combined immunodeficiency (X-linked recessive inheritance)(2) Detected gene name: IL2RG; Location:c.675C> A(maternal origin)

PGT-SR Inspection

1. Chromosome copy number variation (CNV);2. Chromosome structure rearrangement detection examples

(1) Detecting balanced translocation

(2) Chromosome structure rearrangement:46,xY,t(12;14)(q22;q13)(parent)

PGT-P is a derivative of IVF. It is the latest IVF technology that detects multiple genes before embryo implantation. "The whole thing" is deep and refined, and it's the style of medical tea, but the first thing is the vegetable, and you taste the new one."The reason why" it stays behind is

is the line, this heart is dreamt. Weak sex-protective pressing cannot accurately predict disease,[Therefore, it is necessary to integrate multi-gene and multi-locus information., Six-gene diseases are common chronic and complex diseases, such as tumors and hypertension

Diabetes, coronary heart disease, etc. Chronic diseases are a super killer that causes the global disease burden and threatens human health. According to WHO statistics, 70% of deaths every year are caused by chronic diseases.

The intelligent ID matching system uses a fingerprint and face configuration system to enter the fingerprints of both parties corresponding to the individual during the entire test tube cycle when establishing a customer file! D to ensure that sperm and egg harvesting are carried out later

Each step of fertilization, embryo culture, PGT, and transplantation will be verified by the system to ensure that the ID of both parties is correct before proceeding to the next step. Intelligent process management makes medical results more rigorous and ensures that

The results are correct, giving customers more peace of mind.

1. Antagonist Regimen

Suitable for women with various ovarian reserve functions. Treatment can be started as soon as possible after evaluation and physical examination. Antagonists can be added in the middle and late stages of ovulation promotion combined with follicular development and hormone levels. Can flexibly and effectively control early onset L

H peak, the number of oocytes retrieved and the quality of oocytes are guaranteed, the number of days and dose of Gn used are less than those of traditional long regimens, and the incidence of ovarian overstimulation is lower

2. Long Fang Case

It is suitable for patients with normal ovarian reserve function or poor consistency in the early follicular phase. After down-regulating the activity of their reproductive hormone axis after medication in the luteal phase, Gn is used to promote ovulation, combined with follicular growth speed and

Hormone monitoring and adjusting dosage show that the synchronization of follicular development is good, the number of retrieved oocytes and egg quality are guaranteed, and the possibility of early follicular ovulation caused by early LH peak is small

3. High progesterone (PPOS) regimen

Developed from the luteal phase superovulation protocol, it uses a high progesterone state to inhibit the LH peak, replacing traditional antagonists, which can economically save patients. Certain costs, with the advancement of embryo freezing technology

and the application of all embryo freezing strategies, the program can be applied

4. Microstimulation Plan

For elderly people, with reduced ovarian reserve function, or with poor ovulation promotion strategies, the same or similar number of oocytes can be obtained by applying a small dose of Gn. The number of oocytes retrieved can be obtained. The number of days and doses of Gn used are compared with traditional methods

Fewer cases and less ovarian stimulation, suitable for women who need to promote ovulation many times to accumulate follicles

5. Composite emission promotion plan

The latest ovulation promotion plan for older customers and clients with reduced ovarian function promotes ovulation and retrieval during the luteal phase to avoid spontaneous LH spikes and overcome the disadvantages of hyperovulation during the follicular phase. During the single menstrual cycle, eggs are retrieved twice, no

It only improves the quality of eggs and embryos, reduces the number of patient visits, but also saves time costs to a large extent, and medical expenses are greatly halved.

6. Short solution

It is suitable for women with various ovarian reserve functions. Short-acting agonists are usually used from the second day of menstruation until the day of hcG injection, and Gn is used to promote ovulation on the third day. In people with normal ovarian responses, short regimen

The clinical pregnancy rate is lower than that of the long regimen. Currently, the short regimen is mostly used for patients with adverse ovarian reactions